This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent. Top assignee: Boston University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Victoria Lm Herrera in Neutrophil Activation Treatment
Introduction
Victoria Lm Herrera is an accomplished inventor based in Westwood, MA (US). He has made significant contributions to the field of medical research, particularly in the treatment of diseases involving neutrophils. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Victoria Lm Herrera holds a patent for "Methods for treating NETosis and neutrophil activation." This patent describes methods and compositions that inhibit neutrophils, specifically targeting the inhibition of NET release or NETosis through the use of a DEspR inhibitor, such as an anti-DEspR antibody reagent. The methods outlined in the patent can be applied to treat diseases like cancer, where neutrophils and NETs contribute to the worsening of the condition. In some cases, the DEspR inhibitor may be a bi-specific reagent or an antibody-drug conjugate. He has 1 patent to his name.
Career Highlights
Victoria Lm Herrera is affiliated with Boston University, where he conducts his research and development work. His career has been marked by a commitment to advancing medical science and improving treatment options for patients suffering from various diseases.
Collaborations
One of his notable collaborators is Nelson Ruiz-Opazo, with whom he has worked on innovative research projects aimed at enhancing the understanding and treatment of neutrophil-related diseases.
Conclusion
Victoria Lm Herrera's contributions to the field of medical research, particularly through his patent on neutrophil activation treatment, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
